Abstract:Alzheimer's disease (AD) presents a significant societal challenge, with no current cure and an increasing prevalence among older adults. This study addresses the pressing need for early detection by harnessing the potential of machine learning applied to longitudinal MRI data. The dataset, sourced from the Open Access Series of Imaging Studies (OASIS) project, comprises MRI records of 150 subjects aged 60 to 96, each scanned at least once. Notably, 72 subjects were classified as 'Nondemented,' 64 as 'Demented,' and 14 underwent a transition from 'Nondemented' to 'Demented,' forming the 'Converted' category. What we propose is to develop a machine learning sound model capable of predicting the progression of mild cognitive impairment, leveraging key biomarkers extracted from MRI data. The chosen biomarkers include years of education (EDUC), socioeconomic status (SES), Mini-Mental State Examination (MMSE), Clinical Dementia Rating (CDR), Estimated Total Intracranial Volume (eTIV), Normalized Whole Brain Volume (nWBV), and Atlas Scaling Factor (ASF). Prior work in the field is referenced, highlighting studies that predominantly focused on raw MRI data analysis. In contrast, this study introduces a unique approach by utilizing a curated set of biomarkers, allowing for a more targeted and potentially interpretable model. Machine learning models such as Logistic Regression, Support Vector Machine, Decision Tree, Random Forest Classifier, and AdaBoost are employed, with performance measured using established metrics. Information about severity and state are stored during the EADDLS module and used for ADmod. ADmod uses the stored MRI data during the EADDLS module to model the growth of amyloid β build-up in the brain using convolution, resulting in both generalizable approaches and patient-specific approaches. There have been numerous mathematical instantiations to model amyloid β build-up using partial differential equations (or PDEs), these however have remained unincorporated due to prolonged runtimes and storage limitations along with those of pre-set conditions. We propose a novel amyloid β growth model using deep encoder-decoder networks in conjunction with convolution. The study contributes to the growing body of research in early Alzheimer's detection, offering insights, results, and a discussion of limitations. The conclusion outlines a unique approach, emphasizes the practical implementation of the proposed model, acknowledges limitations, and suggests avenues for further research. Early detection of AD can significantly better the patient's quality of care and lead to future preventative or risk assessment measures.

What problem does this paper attempt to address?

This paper attempts to solve the problem of early detection of Alzheimer's Disease (AD). Specifically, the researchers used machine - learning techniques, especially deep - learning methods, combined with longitudinal Magnetic Resonance Imaging (MRI) data, to develop an Early Alzheimer’s Detection Deep Learning System (EADDLS). In addition, the paper also proposed a new spatio - temporal - aware brain amyloid - beta growth model (ADmod), using a deep encoder - decoder network to simulate the accumulation process of amyloid - beta in the brain. ### Research Background and Objectives Alzheimer's disease is a serious social challenge. At present, there is no cure, and the incidence rate among the elderly is increasing year by year. Therefore, early detection is crucial for improving the quality of life of patients. This study aims to develop a machine - learning model capable of predicting the progression of mild cognitive impairment by using machine - learning techniques to process longitudinal MRI data. ### Main Contributions 1. **Dataset**: The data used in the study came from the Open Access Series of Imaging Studies (OASIS) project, which contains MRI records of 150 subjects aged between 60 and 96 years. These subjects were divided into three categories: "non - demented", "demented" and "converted" (from "non - demented" to "demented"). 2. **Feature Selection**: In addition to using the original MRI data, the study also introduced a series of key biomarkers, such as years of education (EDUC), socioeconomic status (SES), Mini - Mental State Examination (MMSE), Clinical Dementia Rating Scale (CDR), estimated total intracranial volume (eTIV), normalized whole - brain volume (nWBV) and atlas scaling factor (ASF). The selection of these biomarkers makes the model more targeted and interpretable. 3. **Model Construction**: The study adopted a variety of machine - learning models, including logistic regression, Support Vector Machines (SVM), decision trees, random forest classifiers and AdaBoost. The model performance was evaluated by metrics such as accuracy, recall and AUC. 4. **ADmod Model**: In order to more accurately simulate the accumulation process of amyloid - beta in the brain, the study proposed an ADmod model based on a deep encoder - decoder network. This model extracts spatial features through convolution operations and uses time - series images for prediction. ### Results and Discussion - **EADDLS Module**: Among the various machine - learning models, the random forest classifier performed the best, with an accuracy of 94.21% and a recall rate of 90% on the test set. - **ADmod Module**: The ADmod model performed excellently in predicting amyloid - beta accumulation, with an RMSE of 0.0204 ± 0.0001, an RRMSE of 0.0013 ± 0.00001 and an RSE of 0.3735 ± 0.0049 on the test set. - **Clinical Application**: The research team developed a user - friendly Web application, allowing clinicians to input MRI results, biological data and other relevant parameters, thereby assisting in the diagnosis of Alzheimer's disease. ### Limitations and Future Research Directions Although the study has achieved remarkable results, there are still some limitations, such as the small size of the dataset and the need for further optimization of the data cleaning and analysis processes. Future research can explore more factors affecting dementia, such as inter - generational grouping, brain tissue volume grading and test scores, and integrate them into the data cleaning process to improve the prediction accuracy of the model. In conclusion, this paper provides new ideas and methods for the early detection of Alzheimer's disease by combining machine - learning and deep - learning techniques, and has important clinical application value.

A quantitative analysis of Alzheimers Disease and construction of an early Alzheimers detection deep learning system (EADDLS) using MRI data via machine learning along with ADmod: spatiotemporal-aware brain-amyloidβ growth model, using deep encoder-decoder networks about MRI

Early Diagnosis of Alzheimer's Disease Using Deep Learning

Comparison of deep learning architectures for predicting amyloid positivity in Alzheimer's disease, mild cognitive impairment, and healthy aging, from T1-weighted brain structural MRI

Early diagnosis of Alzheimer's disease from MRI images with deep learning model

A deep learning model for early prediction of Alzheimer's disease dementia based on hippocampal MRI

DeepAD: A Robust Deep Learning Model of Alzheimer's Disease Progression for Real-World Clinical Applications

A deep learning framework for early diagnosis of Alzheimer's disease on MRI images

A robust and clinically applicable deep learning model for early detection of Alzheimer's

Multimodal Neuroimaging for Early Alzheimer's detection: A Deep Learning Approach

Automated Alzheimer's disease diagnosis using radiomics feature extraction on magnetic resonance images

Long Range Early Diagnosis of Alzheimer's Disease Using Longitudinal MR Imaging Data

Machine Learning for Diagnosis of AD and Prediction of MCI Progression From Brain MRI Using Brain Anatomical Analysis Using Diffeomorphic Deformation

A Machine Learning Approach for Identifying Anatomical Biomarkers of Early Mild Cognitive Impairment

A Single Model Deep Learning Approach for Alzheimer's Disease Diagnosis

Empirical Evaluation of Deep Learning Architectures in the Early Detection of Alzheimer s Disease through MRI Data Analysis

Longitudinal MRI analysis using a hybrid DenseNet-BiLSTM method for Alzheimer's disease prediction

Exploring the power of MRI and clinical measures in predicting Alzheimers disease neuropathology

Deep Learning Approaches for Early Prediction of Conversion from MCI to AD using MRI and Clinical Data: A Systematic Review

Classification of Alzheimer’s disease using MRI data based on Deep Learning Techniques

A Single Model Deep Learning Approach for Alzheimer’s Disease Diagnosis

Development and validation of a deep learning framework for Alzheimer’s disease classification